Li Guangyao, Shi Yuxuan, Liu Quan, Zhang Huankang, Xue Kai, Song Xiaole, Gu Ye, Sun Xicai, Dai Qi, Yu Hongmeng
Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, PR China.
Research Units of New Technologies of Endoscopic Surgery in Skull Base Tumor (2018RU003), Chinese Academy of Medical Sciences, Beijing, PR China.
Acta Otolaryngol. 2023 Feb;143(2):185-190. doi: 10.1080/00016489.2023.2175032. Epub 2023 Feb 13.
In China, reports on the epidemiology of adenocarcinomas of the nasal cavity and paranasal sinuses are limited.
This study aimed to describe the experience of a single institution in China in treating these malignant tumours.
We conducted a retrospective chart review of patients with adenocarcinoma of the nasal cavity and paranasal sinuses admitted between January 2019 and December 2021. Tumour staging was based on the American Joint Committee on Cancer, 8th edition, for sinonasal malignancies.
The series included 10 men and 4 women (mean age, 54.5 [range, 14-80] years). Epistaxis and nasal obstruction were the most common clinical manifestations in 10 (71.4%) patients. Ten (71.4%) had stage T4 disease at diagnosis, but no patient had lymph node or distant metastasis. The posterosuperior septum (100.0%) and middle turbinate (92.8%) were the two sites most vulnerable to tumour invasion. All patients underwent endoscopic resection as the initial treatment; one patient died.
In China, these malignancies are related to exposure to certain substances; however, diagnosis can be delayed. Endoscopic resection is a suitable treatment option for adenocarcinomas of the nasal cavity and paranasal sinuses.
在中国,关于鼻腔和鼻窦腺癌流行病学的报道有限。
本研究旨在描述中国一家机构治疗这些恶性肿瘤的经验。
我们对2019年1月至2021年12月期间收治的鼻腔和鼻窦腺癌患者进行了回顾性病历审查。肿瘤分期基于美国癌症联合委员会第8版鼻窦恶性肿瘤分期标准。
该系列包括10名男性和4名女性(平均年龄54.5岁[范围14 - 80岁])。鼻出血和鼻塞是10名(71.4%)患者最常见的临床表现。10名(71.4%)患者诊断时为T4期疾病,但无患者有淋巴结或远处转移。后上鼻中隔(100.0%)和中鼻甲(92.8%)是最易受肿瘤侵犯的两个部位。所有患者均接受了内镜下切除作为初始治疗;1例患者死亡。
在中国,这些恶性肿瘤与接触某些物质有关;然而,诊断可能会延迟。内镜下切除是鼻腔和鼻窦腺癌合适的治疗选择。